WallStreetZenWallStreetZen

NASDAQ: NARI
INARI MEDICAL INC Stock Forecast, Predictions & Price Target

Analyst price target for NARI

Based on 2 analysts offering 12 month price targets for INARI MEDICAL INC.
Min Forecast
$95.00+59.34%
Avg Forecast
$95.50+60.18%
Max Forecast
$96.00+61.02%

Should I buy or sell NARI stock?

Based on 2 analysts offering ratings for INARI MEDICAL INC.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

NARI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Canaccord Genuity
Bottom 12%
12
Strong BuyMaintains$96.00+61.02%2022-03-14
Anonymous
Morgan Stanley
Strong BuyMaintains$108.00+81.15%2022-02-24
SVB Leerink
Bottom 3%
3
BuyMaintains$95.00+59.34%2022-02-24

1 of 1

Forecast return on equity

Is NARI forecast to generate an efficient return?
Company
2.92%
Industry
27.24%
Market
32.71%
NARI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NARI forecast to generate an efficient return on assets?
Company
2.52%
Industry
14.27%
NARI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NARI earnings per share forecast

What is NARI's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.78
Avg 2 year Forecast
$0.03
Avg 3 year Forecast
$0.43

NARI revenue forecast

What is NARI's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$364.5M+18.98%
Avg 2 year Forecast
$441.6M+44.15%
Avg 3 year Forecast
$511.7M+67.05%
NARI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NARI revenue growth forecast

How is NARI forecast to perform vs Medical Devices companies and vs the US market?
Company
18.74%
Industry
6.05%
Market
9.29%
NARI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NARI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NARI vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
NARI$59.62$95.50+60.18%Strong Buy
CNMD$111.71$165.00+47.70%Strong Buy
LIVN$64.33$100.80+56.69%Strong Buy
NUVA$53.10$63.00+18.64%Strong Buy
ITGR$74.40$104.50+40.46%Strong Buy

INARI MEDICAL Stock Forecast FAQ

Is INARI MEDICAL Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: NARI) stock is to Strong Buy NARI stock.

Out of 2 analysts, 1 (50%) are recommending NARI as a Strong Buy, 1 (50%) are recommending NARI as a Buy, 0 (0%) are recommending NARI as a Hold, 0 (0%) are recommending NARI as a Sell, and 0 (0%) are recommending NARI as a Strong Sell.

What is NARI's earnings growth forecast for 2022-2024?

(NASDAQ: NARI) INARI MEDICAL's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.11%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.78%.

INARI MEDICAL's earnings in 2022 is -$758,000.On average, 3 Wall Street analysts forecast NARI's earnings for 2022 to be -$41,437,839, with the lowest NARI earnings forecast at -$51,000,417, and the highest NARI earnings forecast at -$35,594,041. On average, 3 Wall Street analysts forecast NARI's earnings for 2023 to be $1,593,763, with the lowest NARI earnings forecast at -$8,500,069, and the highest NARI earnings forecast at $8,500,069.

In 2024, NARI is forecast to generate $22,843,937 in earnings, with the lowest earnings forecast at $7,437,561 and the highest earnings forecast at $38,250,312.

What is NARI's revenue growth forecast for 2022-2024?

(NASDAQ: NARI) INARI MEDICAL's forecast annual revenue growth rate of 18.74% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.05%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.29%.

INARI MEDICAL's revenue in 2022 is $306,339,000.On average, 2 Wall Street analysts forecast NARI's revenue for 2022 to be $19,362,892,557, with the lowest NARI revenue forecast at $19,132,593,801, and the highest NARI revenue forecast at $19,593,191,314. On average, 2 Wall Street analysts forecast NARI's revenue for 2023 to be $23,459,926,027, with the lowest NARI revenue forecast at $23,426,191,377, and the highest NARI revenue forecast at $23,493,660,678.

In 2024, NARI is forecast to generate $27,185,612,714 in revenue, with the lowest revenue forecast at $27,098,752,629 and the highest revenue forecast at $27,272,472,798.

What is NARI's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: NARI) forecast ROA is 2.52%, which is lower than the forecast US Medical Devices industry average of 14.27%.

What is NARI's Price Target?

According to 2 Wall Street analysts that have issued a 1 year NARI price target, the average NARI price target is $95.50, with the highest NARI stock price forecast at $96.00 and the lowest NARI stock price forecast at $95.00.

On average, Wall Street analysts predict that INARI MEDICAL's share price could reach $95.50 by Mar 14, 2023. The average INARI MEDICAL stock price prediction forecasts a potential upside of 60.18% from the current NARI share price of $59.62.

What is NARI's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: NARI) INARI MEDICAL's current Earnings Per Share (EPS) is -$0.02. On average, analysts forecast that NARI's EPS will be -$0.78 for 2022, with the lowest EPS forecast at -$0.96, and the highest EPS forecast at -$0.67. On average, analysts forecast that NARI's EPS will be $0.03 for 2023, with the lowest EPS forecast at -$0.16, and the highest EPS forecast at $0.16. In 2024, NARI's EPS is forecast to hit $0.43 (min: $0.14, max: $0.72).

What is NARI's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: NARI) forecast ROE is 2.92%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.